<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Canada</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Canada.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/ca.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Clinical features and outcomes of pediatric breakthrough invasive pneumococcal disease (IPD) in vaccinated children in Calgary, Alberta, Canada, 2003–2024</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128977-f1a84e1c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128977-f1a84e1c/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The article is relevant to pediatric pneumococcal vaccine programs because it describes vaccine-type invasive disease occurring despite vaccination and identifies serotypes highlighted in the abstract as prominent among breakthrough cases.</description>
    <category>Invasive pneumococcal disease</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Using high frequency GPS data to assess wintering goose proximity to commercial poultry facilities on the Delmarva peninsula for avian influenza risk management and surveillance.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0355415-e4d17955/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0355415-e4d17955/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The findings describe a possible way to prioritize biosecurity or surveillance resources around poultry facilities using observed wintering-waterfowl presence. This is an evidence-context signal from the supplied article and does not establish that the ranking method is validated for current surveillance or outbreak prediction.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Emergence of alveolar echinococcosis in Canada: a warning for the USA</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1097-qco-0000000000001229-39e1e4e7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1097-qco-0000000000001229-39e1e4e7/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The authors describe alveolar echinococcosis as an emerging, under-recognized zoonotic disease in Canada and emphasize that early recognition using Em-specific diagnostics, along with a One Health approach integrating human, veterinary, and wildlife data, is needed to reduce morbidity and mortality.</description>
    <category>Echinococcosis</category>
    <category>Treatment</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Factors associated with severe COVID-19 outcomes among adults with at least a primary vaccination schedule: A retrospective cohort study from Alberta, Canada</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0354822-21d017fb/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0354822-21d017fb/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings can inform decision-making, public health strategies, and policy development to protect vaccinated populations at elevated risk. The results support recommendations from Canada&apos;s National Advisory Committee on Immunisation for specific groups to remain current with COVID-19 vaccination to reduce severe outcomes.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Lessons from Ontario’s COVID-19 Vaccination Strategies: Implications for Preventing Measles Resurgence in Canada</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-pandemics1020010-023875f4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-pandemics1020010-023875f4/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The paper addresses the critical public health challenge of measles resurgence in a country that previously achieved elimination. It explores how lessons from pandemic vaccination efforts might inform strategies to restore and maintain routine immunization coverage.</description>
    <category>COVID-19</category>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>2024/25 end-of-season KP.2 vaccine effectiveness against COVID-19 hospitalization in older adults: a test-negative study in Quebec, Canada</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128786-fdce4611/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128786-fdce4611/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings demonstrate that KP.2 vaccine provides meaningful but short-lived protection against COVID-19 hospitalization in older adults, informing vaccination timing and booster strategies for this vulnerable population.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>mRNA COVID-19 vaccine safety in adults from the Canadian national vaccine safety network</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128630-6d3ff677/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128630-6d3ff677/</guid>
    <pubDate>Mon, 01 Jun 2026 00:00:00 GMT</pubDate>
    <description>The findings provide Canadian adult vaccine-safety evidence on short-term health events following two-dose mRNA vaccination and include comparison with an unvaccinated group. The abstract describes symptom frequency and healthcare-utilization outcomes but does not establish longer-term effects or causality.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Vaccine safety</category>
    <category>Surveillance</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Revaccination of individuals with cardiac adverse events following COVID-19 vaccination: A Canadian Immunization Research Network study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2025-128016-0888af7f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2025-128016-0888af7f/</guid>
    <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
    <description>Findings inform clinical guidance on revaccination after cardiac AEFIs, suggesting revaccination may be considered for chest pain not meeting myocarditis criteria while indicating caution for adults with prior myopericarditis.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Vaccine safety</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Understanding the low effectiveness of influenza vaccines in older adults of South Korea: an exploration of contributing factors</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2025-128076-2ff326f2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2025-128076-2ff326f2/</guid>
    <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
    <description>The article highlights a coverage–effectiveness paradox in older adults and outlines candidate policy and platform-level strategies to improve influenza vaccine outcomes in South Korea, with potential global relevance.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Evaluating the Impact of Implementing and Scaling-Up the Use of Syphilis Rapid/Point-of-Care Tests: An Interrupted Time Series Analysis of New Syphilis Positivity Rates in Alberta, Canada</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf651-2c805f85/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf651-2c805f85/</guid>
    <pubDate>Fri, 19 Dec 2025 00:00:00 GMT</pubDate>
    <description>Rapid point-of-care testing enables same-day treatment for individuals in nontraditional settings, addressing barriers to testing and treatment among key populations. The intervention was associated with significant declines in new syphilis positivity rates in a high-income setting experiencing resurgence of heterosexual syphilis transmission.</description>
    <category>Syphilis</category>
    <category>Congenital syphilis</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Evaluating the MedMira Multiplo® Complete Syphilis (TP/nTP) antibody test in a sexually transmitted infection clinic in Ottawa, Canada: increased rapid diagnosis and improved antibiotic stewardship</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-025-12263-w-cfa51897/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-025-12263-w-cfa51897/</guid>
    <pubDate>Mon, 08 Dec 2025 00:00:00 GMT</pubDate>
    <description>Accelerated diagnostic workflows may streamline clinical decision-making and support antimicrobial stewardship by clarifying infection status prior to therapeutic decisions.</description>
    <category>Syphilis</category>
    <category>Infectious syphilis</category>
    <category>Treatment</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Using COVID-19 pandemic perturbation to model RSV-hMPV interactions and potential implications under RSV interventions</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41467-025-62358-w-8c544db8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41467-025-62358-w-8c544db8/</guid>
    <pubDate>Wed, 06 Aug 2025 00:00:00 GMT</pubDate>
    <description>Findings provide a modeling foundation for anticipating possible hMPV dynamics when RSV immunization strategies are deployed.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Transmission dynamics</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Cost-Effectiveness of Antiviral Drugs to Prevent or Treat Influenza A, Influenza B, or Zoonotic Influenza</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-51731-cjht-2025-1153-7691e253/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-51731-cjht-2025-1153-7691e253/</guid>
    <pubDate>Thu, 26 Jun 2025 00:00:00 GMT</pubDate>
    <description>Assessing the economic performance of antiviral regimens aids decision-makers in optimizing budget distribution for seasonal outbreaks and emergency preparedness. Recognizing financially sustainable treatment pathways supports long-term healthcare system resilience against emerging viral threats.</description>
    <category>Influenza</category>
    <category>One Health</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Measles in Canada: modelling outbreaks with variable vaccine coverage and interventions</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-025-10564-8-7db4e517/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-025-10564-8-7db4e517/</guid>
    <pubDate>Wed, 19 Feb 2025 00:00:00 GMT</pubDate>
    <description>The work is positioned as a downstream tool that translates global measles activity into local Canadian outbreak projections of duration and size, with potential utility for informing public communication about measles-related risk.</description>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Chikungunya vaccine development, challenges, and pathway toward public health impact</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2024-126483-c93e4b57/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2024-126483-c93e4b57/</guid>
    <pubDate>Sun, 01 Dec 2024 00:00:00 GMT</pubDate>
    <description>The article is relevant to decisions about chikungunya vaccine introduction, financing, manufacturing scale-up, equitable distribution, and demand generation in at-risk populations. It identifies evidence on disease burden and vaccination impact as important inputs for such decisions.</description>
    <category>Chikungunya</category>
    <category>Malaria</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Outbreak investigation</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>A wastewater-based epidemic model for SARS-CoV-2 with application to three Canadian cities</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-epidem-2022-100560-81dd0d72/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-epidem-2022-100560-81dd0d72/</guid>
    <pubDate>Wed, 01 Jun 2022 00:00:00 GMT</pubDate>
    <description>The paper describes wastewater surveillance combined with modelling as a potential complementary source for estimating epidemiological measures when interpreting clinical and wastewater signals together. The abstract states that this approach may support broader assessment of epidemic conditions, but it does not establish performance for operational public-health decisions.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Surveillance</category>
    <category>Climate and environment</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2504-171630-f275d8b2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2504-171630-f275d8b2/</guid>
    <pubDate>Mon, 01 Apr 2019 00:00:00 GMT</pubDate>
    <description>The findings are positioned as evidence to inform policy decisions on preimmigration LTBI screening for migrants to low-incidence countries, alongside further research on sustainability, acceptability, and program implementation.</description>
    <category>Tuberculosis</category>
    <category>Treatment</category>
    <category>Diagnostics</category>
    <category>Climate and environment</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2019-24-4-1900055-8d6951d4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2019-24-4-1900055-8d6951d4/</guid>
    <pubDate>Thu, 24 Jan 2019 00:00:00 GMT</pubDate>
    <description>The findings document substantial seasonal influenza vaccine protection against the predominant circulating strain during the 2018/19 season, with particular relevance for young children who experienced disproportionate disease burden.</description>
    <category>Influenza</category>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Foodborne Botulism in Canada, 1985–2005</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid1906-120873-97f3c032/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid1906-120873-97f3c032/</guid>
    <pubDate>Sat, 01 Jun 2013 00:00:00 GMT</pubDate>
    <description>The findings highlight persistent foodborne botulism risk associated with traditional food preparation practices in specific indigenous populations and underscore the importance of early diagnosis and treatment in reducing mortality. Sporadic outbreaks linked to commercial and restaurant foods indicate broader surveillance needs.</description>
    <category>Botulism</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
